Marshall Wace North America’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $558K | Buy |
+2,363
| New | +$558K | ﹤0.01% | 1048 |
|
|
2021
Q2 | – | Sell |
-8,616
| Closed | -$3.49M | – | 1584 |
|
|
2021
Q1 | $3.49M | Buy |
8,616
+5,268
| +157% | +$2.13M | 0.01% | 652 |
|
|
2020
Q4 | $2.23M | Buy |
+3,348
| New | +$2.23M | 0.01% | 726 |
|
|
2020
Q3 | – | Sell |
-25,127
| Closed | -$14.7M | – | 1381 |
|
|
2020
Q2 | $14.7M | Buy |
+25,127
| New | +$14.7M | 0.1% | 216 |
|